During their November 2018 meeting, the Board approved a guidance document for its licensees relative to the sale of CBD oil. That guidance document referenced relevant federal and state laws. The referenced federal law changed in December 2018 with the passage of the 2018 Farm Bill. However, state law has not yet changed. In the interim, state law is more stringent than federal law.
During their February 19, 2019 meeting, the Board voted to revise its original guidance document by removing the references to federal law but left intact the references to the current state law. Finally, its ultimate guidance remains the same: the sale of CBD oil by its licensees would constitute a violation of the state controlled substance law and place them at risk for criminal and/or administrative sanctions.
The Revised Guidance Document for CBD Oil is available on the Board's website at www.pharmacy.la.gov by visiting the Public Library, then selecting the link for Declaratory Statements, Advisory Opinions & Policy Statements.